Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy

29 Mar 2023

Abstract excerpt

The realm of cell-based immunotherapy holds untapped potential for the development of next-generation cancer treatment through genetic engineering of chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapies for targeted eradication of cancerous malignancies. Such allogeneic "off-the-shelf" cell products can be advantageously manufactured in large quantities, stored for extended periods, and easily...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Nanowire Synthesis and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37064017
DOI: 10.3389/fmed.2023.1135468

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapyPMID 37064017Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantationSemantic proximity Read ↗

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity Read ↗

Genetically engineered T cells for cancer immunotherapySemantic proximity Read ↗

Application and prospects of genetic engineering in CAR-NK cell therapySemantic proximity Read ↗

Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?Semantic proximity Read ↗

Engineering strategies to safely drive CAR T-cells into the futureSemantic proximity Read ↗

Genetically modified T cells in cancer therapy: opportunities and challengesSemantic proximity Read ↗

Strategies to genetically engineer T cells for cancer immunotherapySemantic proximity Read ↗

Chimeric Antigen Receptor T-cell Therapy to Target Hematologic MalignanciesSemantic proximity Read ↗

Clinical application of genetically modified T cells in cancer therapySemantic proximity Read ↗

Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.